Low EIF2B5 expression predicts poor prognosis in ovarian cancer

Ovarian cancer has the highest mortality among gynecological cancers. Although ovarian cancer usually responds well to chemotherapy, most patients still have a poor prognosis. EIF2B5 is a crucial molecule in posttranscriptional modifications involved in tumor progression, and here we investigated th...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Lin, Jiao, Yan, Li, Yanqing, Luo, Zhangping, Zhang, Xueying, Pan, Guoqiang, Zhao, Yuechen, Yang, Zhaoying, He, Miao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004721/
https://www.ncbi.nlm.nih.gov/pubmed/32000373
http://dx.doi.org/10.1097/MD.0000000000018666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7004721/
https://www.ncbi.nlm.nih.gov/pubmed/32000373
http://dx.doi.org/10.1097/MD.0000000000018666

Ejemplares similares